Dupilumab treatment for severe chronic rhinosinusitis with nasal polyps: efficacy and impact on co-existing mild to moderate asthma

Niki Papapostolou, Michael Makris

Open source

DOI
10.37349/eaa.2024.00039
Published
2024-06-06
Container
Exploration of Asthma & Allergy
Publisher
Open Exploration Publishing
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.37349/eaa.2024.00039,
  title = {Dupilumab treatment for severe chronic rhinosinusitis with nasal polyps: efficacy and impact on co-existing mild to moderate asthma},
  author = {Niki Papapostolou and Michael Makris},
  year = {2024},
  journal = {Exploration of Asthma \& Allergy},
  doi = {10.37349/eaa.2024.00039},
  url = {https://doi.org/10.37349/eaa.2024.00039}
}

RIS

TY  - JOUR
TI  - Dupilumab treatment for severe chronic rhinosinusitis with nasal polyps: efficacy and impact on co-existing mild to moderate asthma
AU  - Niki Papapostolou
AU  - Michael Makris
PY  - 2024
JO  - Exploration of Asthma & Allergy
DO  - 10.37349/eaa.2024.00039
UR  - https://doi.org/10.37349/eaa.2024.00039
ER  - 

APA

Papapostolou, N., & Makris, M. (2024). Dupilumab treatment for severe chronic rhinosinusitis with nasal polyps: efficacy and impact on co-existing mild to moderate asthma. Exploration of Asthma & Allergy. https://doi.org/10.37349/eaa.2024.00039

Source records